Limnopharma signs a Research Agreement with “Fundación Progreso y Salud”, an organization which belongs to the Andalusian Region Ministry of Health (Spain).

The agreement includes the execution of the “Lead retina” research project, led by Dr. Dr. Díaz-Corrales, to analyze the efficacy and safety of our lead drug targeting Retinitis Pigmentosa (RP). The Project includes the assay, using a mouse model for RP (RD-10 mice) of a series of polyphenolic compounds, Limnopharma’s own technology, to select the best candidate as treatment for RP.

This agreement constitutes a step forward in our collaboration with FPS, employer of our co-founder, DR. Díaz-Corrales, and owner of one of the patents exclusively licensed by Limnopharma. Let’s hope a fruitful collaboration for years to come!